The online version of this article (https://doi.org/10.1007/s00520-019-05258-2) contains supplementary material, which is available to authorized users.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
To evaluate the feasibility of oral cryotherapy (OC) in children and to investigate if OC reduces the incidence of severe oral mucositis (OM), oral pain, and opioid use in children undergoing hematopoietic stem cell transplantation (HSCT).
Fifty-three children, 4–17 years old, scheduled for HSCT in Sweden were included and randomized to OC or control using a computer-generated list. OC instructions were to cool the mouth with ice for as long as possible during chemotherapy infusions with an intended time of ≥ 30 min. Feasibility criteria in the OC group were as follows: (1) compliance ≥ 70%; (2) considerable discomfort during OC < 20%; (3) no serious adverse events; and (4) ice administered to all children. Grade of OM and oral pain was recorded daily using the WHO-Oral Toxicity Scale (WHO-OTS), Children’s International Oral Mucositis Evaluation Scale, and Numerical Rating Scale. Use of opioids was collected from the medical records.
Forty-nine children (mean age 10.5 years) were included in analysis (OC = 26, control = 23). The feasibility criteria were not met. Compliance was poor, especially for the younger children, and only 15 children (58%) used OC as instructed. Severe OM (WHO-OTS ≥ 3) was recorded in 26 children (OC = 15, control = 11). OC did not reduce the incidence of severe OM, oral pain, or opioid use.
The feasibility criteria were not met, and the RCT could not show that OC reduces the incidence of severe OM, oral pain, or opioid use in pediatric patients treated with a variety of conditioning regimens for HSCT.
ClinicalTrials.gov id: NCT01789658
Sonis ST, Elting LS, Keefe D, Peterson DE, Schubert M, Hauer-Jensen M, Bekele BN, Raber-Durlacher J, Donnelly JP, Rubenstein EB (2004) Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients. Cancer 100:1995–2025. https://doi.org/10.1002/cncr.20162 CrossRefPubMed
Vagliano L, Feraut C, Gobetto G, Trunfio A, Errico A, Campani V, Costazza G, Mega A, Matozzo V, Berni M, Alberani F, Banfi MM, Martinelli L, Munaron S, Orlando L, Lubiato L, Leanza S, Guerrato R, Rossetti A, Messina M, Barzetti L, Satta G, Dimonte V (2011) Incidence and severity of oral mucositis in patients undergoing haematopoietic SCT-results of a multicentre study. Bone Marrow Transplant 46:727–732. https://doi.org/10.1038/bmt.2010.184 CrossRefPubMed
Kamsvag-Magnusson T, Thorsell-Cederberg J, Svanberg A, von Essen L, Arvidson J, Mellgren K, Toporski J, Ljungman G (2014) Parents and children’s perceptions of distress related to oral mucositis during haematopoietic stem cell transplantation. Acta Paediatr 103:630–636. https://doi.org/10.1111/apa.12627 CrossRefPubMedPubMedCentral
Cheng KK, Lee V, Li CH, Goggins W, Thompson DR, Yuen HL, Epstein JB (2011) Incidence and risk factors of oral mucositis in paediatric and adolescent patients undergoing chemotherapy. Oral Oncol 47:153–162. https://doi.org/10.1016/j.oraloncology.2010.11.019 CrossRefPubMed
Sonis ST, Oster G, Fuchs H, Bellm L, Bradford WZ, Edelsberg J, Hayden V, Eilers J, Epstein JB, LeVeque F, Miller C, Peterson DE, Schubert MM, Spijkervet FK, Horowitz M (2001) Oral mucositis and the clinical and economical outcomes of hematopoietic stem-cell transplantation. J Clin Oncol 19:2201–2205. https://doi.org/10.1200/JCO.2001.19.9.2201 CrossRefPubMed
Worthington HV, Clarkson JE, Bryan G, Furness S, Glenny AM, Littlewood A, McCabe MG, Meyer S, Khalid T (2011) Interventions for preventing oral mucositis for patients with cancer receiving treatment. Cochrane Database Syst Rev 4:CD000978. https://doi.org/10.1002/14651858.CD000978.pub5 CrossRef
Clarkson JE, Worthington HV, Furness S, McCabe M, Khalid T, Meyer S (2010) Interventions for treating oral mucositis for patients with cancer receiving treatment. Cochrane Database System Rev 8:CD001973. https://doi.org/10.1002/14651858.CD001973.pub4 CrossRef
Lalla RV, Bowen J, Barasch A, Elting L, Epstein J, Keefe DM, McGuire DB, Migliorati C, Nicolatou-Galitis O, Peterson DE, Raber-Durlacher JE, Sonis ST, Elad S (2014) MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy. Cancer 120:1453–1461. https://doi.org/10.1002/cncr.28592 CrossRefPubMedPubMedCentral
Glenny AM, Gibson F, Auld E, Coulson S, Clarkson JE, Craig JV, Eden OB, Khalid T, Worthington HV, Pizer B (2010) The development of evidence-based guidelines on mouth care for children, teenagers and young adults treated for cancer. Eur J Cancer 46:1399–1412. https://doi.org/10.1016/j.ejca.2010.01.023 CrossRefPubMed
Sung L, Robinson P, Treister N, Baggott T, Gibson P, Tissing W, Wiernikowski J, Brinklow J, Dupuis LL (2015) Guideline for the prevention of oral and oropharyngeal mucositis in children receiving treatment for cancer or undergoing haematopoietic stem cell transplantation. BMJ Support Palliat Care 7:7–16. https://doi.org/10.1136/bmjspcare-2014-000804 CrossRefPubMedPubMedCentral
Riley P, Glenny AM, Worthington HV, Littlewood A, Clarkson JE, McCabe MG (2015) Interventions for preventing oral mucositis in patients with cancer receiving treatment: oral cryotherapy. Cochrane Database System Rev 12:CD011552. https://doi.org/10.1002/14651858.CD011552.pub2 CrossRef
Peterson DE, Ohrn K, Bowen J, Fliedner M, Lees J, Loprinzi C, Mori T, Osaguona A, Weikel DS, Elad S, Lalla RV (2013) Systematic review of oral cryotherapy for management of oral mucositis caused by cancer therapy. Support Care Cancer 21:327–332. https://doi.org/10.1007/s00520-012-1562-0 CrossRefPubMed
World Health Organization (1979) WHO handbook for reporting results of cancer treatment, vol 48. World Health Organization, Geneva, pp116–17
Tomlinson D, Gibson F, Treister N, Baggott C, Judd P, Hendershot E, Maloney AM, Doyle J, Feldman B, Kwong K, Sung L (2010) Refinement of the Children’s International Mucositis Evaluation Scale (ChIMES): child and parent perspectives on understandability, content validity and acceptability. Eur J Oncol Nurs 14:29–41. https://doi.org/10.1016/j.ejon.2009.10.004 CrossRefPubMed
Tomlinson D, Gibson F, Treister N, Baggott C, Judd P, Hendershot E, Maloney AM, Doyle J, Feldman B, Kwong K, Sung L (2009) Understandability, content validity, and overall acceptability of the Children’s International Mucositis Evaluation Scale (ChIMES): child and parent reporting. J Pediatr Hematol Oncol 31:416–423. https://doi.org/10.1097/MPH.0b013e31819c21ab CrossRefPubMed
Sprangers MA, Cull A, Groenvold M, Bjordal K, Blazeby J, Aaronson NK (1998) The European Organization for Research and Treatment of Cancer approach to developing questionnaire modules: an update and overview. EORTIC Quality of Life Study Group Qual Life Res 7:291–300 CrossRef
Hicks CL, von Baeyer CL, Spafford PA, van Korlaar I, Goodenough B (2001) The Faces Pain Scale-Revised: toward a common metric in pediatric pain measurement. Pain 93:173–183 CrossRef
McGrath PJ, Walco GA, Turk DC, Dworkin RH, Brown MT, Davidson K, Eccleston C, Finley GA, Goldschneider K, Haverkos L, Hertz SH, Ljungman G, Palermo T, Rappaport BA, Rhodes T, Schechter N, Scott J, Sethna N, Svensson OK, Stinson J, von Baeyer CL, Walker L, Weisman S, White RE, Zajicek A, Zeltzer L, PedIMMPACT (2008) Core outcome domains and measures for pediatric acute and chronic/recurrent pain clinical trials: PedIMMPACT recommendations. J Pain 9:771–783. https://doi.org/10.1016/j.jpain.2008.04.007 CrossRefPubMed
von Baeyer CL, Spagrud LJ, McCormick JC, Choo E, Neville K, Connelly MA (2009) Three new datasets supporting use of the Numerical Rating Scale (NRS-11) for children’s self-reports of pain intensity. Pain 143:223–227. https://doi.org/10.1016/j.pain.2009.03.002 CrossRef
Todd KH, Funk JP (1996) The minimum clinically important difference in physician-assigned visual analog pain scores. Academ Emerg Med 3:142–146 CrossRef
Todd KH, Funk KG, Funk JP, Bonacci R (1996) Clinical significance of reported changes in pain severity. Ann Emerg Med 27:485–489 CrossRef
Heden LE, von Essen L, Ljungman G (2011) Effect of morphine in needle procedures in children with cancer. Eur J Pain 15:1056–1060. https://doi.org/10.1016/j.ejpain.2011.05.010 CrossRefPubMed
Rubin DB (1987) Multiple imputation for nonresponse in surveys. Wiley, p 64
Sorensen JB, Skovsgaard T, Bork E, Damstrup L, Ingeberg S (2008) Double-blind, placebo controlled, randomized study of chlorhexidine prophylaxis for 5-fluorouracil-based chemotherapy-induced oral mucositis with nonblinded randomized comparision to orall coolin (cryotherapy)in gastrointestinal malignancies. Cancer 112:1600–1606. https://doi.org/10.1002/cncr.23328 CrossRefPubMed
Sato A, Saisho-Hattori T, Koizumi Y, Minegishi M, Iinuma K, Imaizumi M (2006) Prophylaxis of mucosal toxicity by oral propantheline and cryotherapy in children with malignancies undergoing myeloablative chemo-radiotherapy. Tohoku J Exp Med 210:315–320 CrossRef
Legert KG, Tsilingaridis G, Remberger M, Ringden O, Heimdahl A, Yucel-Lindberg T, Dahllof G (2015) The relationship between oral mucositis and levels of pro-inflammatory cytokines in serum and in gingival crevicular fluid in allogeneic stem cell recipients. Support Care Cancer 23:1749–1757. https://doi.org/10.1007/s00520-014-2538-z CrossRefPubMed
Legert KG, Remberger M, Ringden O, Heimdahl A, Dahllof G (2014) Reduced intensity conditioning and oral care measures prevent oral mucositis and reduces days of hospitalization in allogeneic stem cell transplantation recipients. Support Care Cancer 22:2133–2140. https://doi.org/10.1007/s00520-014-2190-7 CrossRefPubMed
- Prevention of oral mucositis with cryotherapy in children undergoing hematopoietic stem cell transplantations—a feasibility study and randomized controlled trial
Karin Garming Legert
Louise von Essen
- Springer Berlin Heidelberg
Supportive Care in Cancer
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
Neu im Fachgebiet Onkologie
Mail Icon II